Although transactions were down, they exceeded more than $450 million last month.
For medical device manufacturers, the American Invents Act created several challenges related to patent marking.
Analysts expect 2020 to be a busy year for M&A activity.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
Overall activity in deals jumped 11% in North America.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
It’s too early to tell how the new administration will affect the device industry, but user fees, the ACA and the FDA regulatory process are top of mind.